AI Science Tracker
EN

A deep learning ensemble framework for multi-subtype renal tumor classification using contrast-enhanced CT.

Not stated in the abstract reviewed · 30 Jan 2026 · medicine

Discovery

A deep learning ensemble framework for multi-subtype renal tumor classification using contrast-enhanced CT.

Source check: Source checked. Not independent scientific confirmation.

Finding: Ensemble CNN/LSTM/image-feature classifiers evaluate contrast-enhanced CT from 280 patients with biopsy-confirmed renal tumors across benign/malignant and histological subtypes; reported accuracies range from 91.2% to 100% for subtype tasks. This is retrospective diagnostic validation against histopathology in one cohort; performance estimates are limited by sample size/split and not clinical deployment.

Technology: Original Methods examined; learned operation linked to the stated result as summarized in reason.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Original Methods examined; learned operation linked to the stated result as summarized in reason.
Test and result
Original Results/Conclusion passages examined; outcome and limitations summarized in reason.
Limitation / still unknown
Original Methods/Results establish the cohort, reference/comparison and validation scope as summarized in reason.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.nature.com/articles/s41598-026-37283-7

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.